Merck Serono first to launch application for Haselmeier's Axis-D
2 October 2011
Merck Serono has launched the first application of the Axis-D
pen platform comissioned from Swiss company Haselmeier. The new
injection device has been designed to allow self injection by patients
of a ready-to-use biopharmaceutical solution for injection.
Haselmeier's Axis-D Pen System is a disposable, variable-dose
injection device designed for use with a 3ml cartridge.
Volker Wirth, Director Business Development & Marketing at
Haselmeier, said, “With the Axis pen platform it is easy to tailor
the injection device to various needs. Following our client’s
specifications, we have developed a device that enables users to
adjust the volume of the injection and reuse the pen several times
until the cartridge is empty. For security reasons, we added a
function to the pen to immediately confirm that a complete dose was
delivered, or to indicate the missing amount if an incomplete dose
The Axis pen platform is available as a reusable or disposable
multi-use pen which features adjustable dosing. The pen design is
based on an innovative technology featuring a sliding dose window
which allows easy reading of the dose and provides reduced risk of
incorrect dosing. Available in metal or plastic, the Axis pen is
compatible with 3ml cartridges, all fill volumes and can be
customized to meet any patient needs.